Huakang Biomedical Holdings Company Limited (HKG:8622)

HKG:8622 Statistics

Total Valuation

HKG:8622 has a market cap or net worth of HKD 170.16 million. The enterprise value is 135.67 million.

Market Cap	170.16M
Enterprise Value	135.67M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:8622 has 500.47 million shares outstanding. The number of shares has increased by 15.98% in one year.

Current Share Class	500.47M
Shares Outstanding	500.47M
Shares Change (YoY)	+15.98%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	54.14%
Owned by Institutions (%)	n/a
Float	229.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.31
PB Ratio	2.96
P/TBV Ratio	2.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-30.66
EV / Sales	5.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.23

Financial Position

The company has a current ratio of 4.90, with a Debt / Equity ratio of 0.08.

Current Ratio	4.90
Quick Ratio	4.21
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.81
Interest Coverage	-58.27

Financial Efficiency

Return on equity (ROE) is -7.91% and return on invested capital (ROIC) is -5.48%.

Return on Equity (ROE)	-7.91%
Return on Assets (ROA)	-4.80%
Return on Invested Capital (ROIC)	-5.48%
Return on Capital Employed (ROCE)	-9.27%
Revenue Per Employee	296,553
Profits Per Employee	-48,624
Employee Count	91
Asset Turnover	0.39
Inventory Turnover	2.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +217.76% in the last 52 weeks. The beta is 0.62, so HKG:8622's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+217.76%
50-Day Moving Average	0.40
200-Day Moving Average	0.29
Relative Strength Index (RSI)	37.42
Average Volume (20 Days)	386,200

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:8622 had revenue of HKD 26.99 million and -4.42 million in losses. Loss per share was -0.01.

Revenue	26.99M
Gross Profit	18.17M
Operating Income	-5.33M
Pretax Income	-4.42M
Net Income	-4.42M
EBITDA	-3.71M
EBIT	-5.33M
Loss Per Share	-0.01

Balance Sheet

The company has 38.84 million in cash and 4.35 million in debt, giving a net cash position of 34.49 million or 0.07 per share.

Cash & Cash Equivalents	38.84M
Total Debt	4.35M
Net Cash	34.49M
Net Cash Per Share	0.07
Equity (Book Value)	57.52M
Book Value Per Share	0.11
Working Capital	46.35M

Cash Flow

In the last 12 months, operating cash flow was -3.26 million and capital expenditures -2.12 million, giving a free cash flow of -5.38 million.

Operating Cash Flow	-3.26M
Capital Expenditures	-2.12M
Free Cash Flow	-5.38M
FCF Per Share	-0.01

Margins

Gross margin is 67.32%, with operating and profit margins of -19.76% and -16.40%.

Gross Margin	67.32%
Operating Margin	-19.76%
Pretax Margin	-16.40%
Profit Margin	-16.40%
EBITDA Margin	-13.75%
EBIT Margin	-19.76%
FCF Margin	n/a

Dividends & Yields

HKG:8622 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.98%
Shareholder Yield	n/a
Earnings Yield	-2.60%
FCF Yield	-3.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:8622 has an Altman Z-Score of 4.06 and a Piotroski F-Score of 4.

Altman Z-Score	4.06
Piotroski F-Score	4